HomeNUZ • ASX
add
Neurizon Therapeutics Ltd
Previous close
$0.085
Year range
$0.081 - $0.18
Market cap
63.76M AUD
Avg Volume
433.01K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
In the news
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 3.20K | -94.19% |
Operating expense | 4.72M | 125.08% |
Net income | -57.44K | 98.42% |
Net profit margin | -145.62K | -25,485.98% |
Earnings per share | — | — |
EBITDA | -4.72M | -124.13% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.18M | 2,706.17% |
Total assets | 423.48K | 29.23% |
Total liabilities | 1.54M | 71.55% |
Total equity | 183.11K | — |
Shares outstanding | 17.66M | — |
Price to book | 8.50 | — |
Return on assets | -34.10% | — |
Return on capital | -78.86% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -57.44K | 98.42% |
Cash from operations | -32.68K | -4,407.86% |
Cash from investing | -735.00 | 97.12% |
Cash from financing | -12.11K | -746.12% |
Net change in cash | -45.52K | -64.30% |
Free cash flow | -21.00K | -145.31% |
About
Founded
2000
Website
Employees
52
